Evaluation of the PCSK9 vaccine (V2 vaccine) in male <i>ApoE-deficient mice</i> (N = 5–7). by Ryo Kawakami (4849549)

Screening of PCSK9 peptide vaccines in male <i>ApoE-deficient mice</i>. by Ryo Kawakami (4849549)

ACBC decreases both the amplitude and the decay time of the postsynaptic eNEPSC. by Alex M. Lench (772478)

Pretreatment with ATZ decreased the level of CYP2E1 in APAP exposed mice. by Yuping Jing (725667)

Decreased NO concentrations and impairment of eNOS localization in EHD2 del/del mesenteric arteries. by Claudia Matthaeus (7485782)

“…See also <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0223620#pone.0223620.s005" target="_blank">S4 Fig</a>. (E) Plasma membrane eNOS staining was analyzed and revealed decreased eNOS fluorescence intensity in EHD2 del/del mesenteric arteries compared to EHD2 del/+ (n(del/+) = 83/3; n(del/del) = 81/3). …”

Datasheet1_Impact of lockdown on children with type-1 diabetes: returning to the community was associated with a decrease in HbA1c.pdf by Benjamin Morat (17677977)

“…No significant difference was observed between medians of HbA1c_mean and HbA1c_after values (8.37% [7.88; 9.32%] vs. 8.50% [7.70; 9.50%], respectively; p = 0.391). …”

Datasheet2_Impact of lockdown on children with type-1 diabetes: returning to the community was associated with a decrease in HbA1c.pdf by Benjamin Morat (17677977)

“…No significant difference was observed between medians of HbA1c_mean and HbA1c_after values (8.37% [7.88; 9.32%] vs. 8.50% [7.70; 9.50%], respectively; p = 0.391). …”

Numbers of all fractures, arranged in order of decreasing mean age and with proportion of each of the fracture types in patients over 50, 65, and 75 years of age. by Camilla Bergh (9904522)

“…<p>Numbers of all fractures, arranged in order of decreasing mean age and with proportion of each of the fracture types in patients over 50, 65, and 75 years of age.…”

Effect of <i>bipA</i> deletion on biofilm formation in <i>E. coli</i> and <i>S</i>. Typhimurium. by Eunsil Choi (8271039)

Large state-wide variation (8.6-fold) in number of clozapine prescriptions per thousand Medicare Part D enrollees in 2018 ^a indicates ≥1.50 SD (17.9) from the mean (32.9... by Luke R. Cavanah (19022435)

Large state-wide variation (11.1-fold) in number of clozapine prescriptions per thousand Medicare Part D enrollees in 2015 ^a indicates ≥1.50 SD (20.2) from the mean (36.... by Luke R. Cavanah (19022435)

Large state-wide variation (8.6-fold) in number of clozapine prescriptions per thousand Medicare Part D enrollees in 2017 ^a indicates ≥1.50 SD (18.0) from the mean (33.1... by Luke R. Cavanah (19022435)

Large state-wide variation (8.5-fold) in number of clozapine prescriptions per thousand Medicare Part D enrollees in 2019 ^a indicates ≥1.50 SD (16.8) from the mean (31.0... by Luke R. Cavanah (19022435)

Large state-wide variation (8.6-fold) in number of clozapine prescriptions per thousand Medicare Part D enrollees in 2020 ^a indicates ≥1.50 SD (16.0) from the mean (29.9... by Luke R. Cavanah (19022435)

Large state-wide variation (10.2-fold) in number of clozapine prescriptions per thousand Medicare Part D enrollees in 2016 ^a indicates ≥1.50 SD (19.2) from the mean (34.... by Luke R. Cavanah (19022435)

Fructose diet decreases APAP hepatoxicity. by Sungjoon Cho (4385851)

Subjects:

Lethal time (mean LT₅₀ and LT₉₀ with 95% confidence limits) for aphid populations from different agroecological zones exposed to six entomopathogenic fungal i... by Aime Cheoh Enoh (20141758)

Data Sheet 2_Circulating prostaglandin E2 concentrations decrease at birth in premature lambs.docx by Timothy J. R. Panneflek (22702136)

“…Rationale<p>During pregnancy, prostaglandin E₂ (PGE₂) is released from the placenta and circulates in relatively high concentrations in the fetus. …”

MUC1 and MUC16 are expressed on the surface of human airway organoid-derived air-liquid interface cultures and decreases upon StcE treatment. by Maitrayee Chatterjee (16814693)

Synthesis and Biological Evaluation of MEK/mTOR Multifunctional Inhibitors as Novel Anticancer Agents by Marcian E. Van Dort (21374093)

Subjects: